ERBB2 and breast cancer: Clinical classification of BC is done by assessing histological type, grade, stage and receptor status where tumors can be categorized as estrogen receptor positive (ER+), and/or human epidermal growth factor receptor 2 positive (HER2+), or triple negative (TN) [2].